Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8318-8331

  Günther, Stephan ^a   Piwon, Nils ^a   Iwanska, Alicja ^a   Schilling, Ralf ^a   Meisel, Helga ^b   Will, Hans ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NUCLEAR FACTOR I; POL PROTEIN; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; DNA BASE COMPOSITION; ENHANCER REGION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0029914072     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8318-8331.1996     Document Type: Article

References (61)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Arii, M., S. Takada, and K. Koike. 1992. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7:397-403.
3. Barlet, V., J. P. Zarski, M. A. Thelu, P. Bichard, and J. M. Seigneurin. 1994 Different prevalence of precore mutants in five members of a hepatitis-B-virus-infected family: evidence for a precore variant type in an asymptomatic anti-HBs patient. J. Hepatol. 21:797-805.
4. Blum, H. E., Z.-S. Zhang, E. Galun, F. von Weizsäcker, B. Garner, T. J. Liang, and J. R. Wands. 1992. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J. Virol. 66:1223-1227.
5. Chang, H.-K., B.-Y. Wang, C.-H. Yuh, C-L. Wei, and L.-P. Ting. 1989. A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis B virus. Mol. Cell. Biol. 9:5189-5197.
6. Chen, I.-H., C.-J. Huang, and L.-P. Ting. 1995. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J. Virol. 69:3647-3657.
7. Costa, R. H. 1994. Hepatocyte nuclear factor 3/forkhead protein family: mammalian transcription factors that possess divergent cellular expression patterns and binding specificities, p. 155-181. In F. Tronche and M. Yaniv (ed.), Liver gene expression. R. G. Landes Company, Austin, Tex.
8. Cullen, B. R., and M. H. Malim. 1992. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216:362-368.
9. Fouillot, N., S. Tlouzeau, J.-M. Rossignol, and O. Jean-Jean. 1993. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation. J. Virol. 67:4886-4895.
10. Fourel, G. Personal communication.
11. Fukuda, R., X.-T. Nguyen, N. Ishimura, S. Ishihara, A. Chowdhury, N. Kohge, S. Akagi, M. Watanabe, and S. Fukumoto. 1995. X gene and precore region mutations in the hepatitis B virus genome in persons positive for antibody to hepatitis B e antigen: comparison between asymptomatic "healthy" carriers and patients with severe chronic active hepatitis. J. Infect. Dis. 172:1191-1197.
12. Galibert, F., E. Mandart. F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B genome (subtype ayw) cloned in E. coli. Nature (London) 281:646-650.
13. Ganem, D. 1996. Hcpadnaviridae and their replication, p. 2703-2737. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), virology. 3rd ed. Lippincott-Raven Publishers, Philadelphia.
14. Gotoh, K., S. Mima, T. Uchida, T. Shikata, K. Yoshizawa, M. Irie, and M. Mizui. 1995. Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J. Med. Virol. 46:201-206.
15. Günther, S., S. Baginski, H. Kissel, P. Reinke, D. H. Krüger, H. Will, and H. Meisel. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease, Hepatology, in press.
16. Günther, S., B.-C. Li, S. Miska, D. H. Krüger, H. Meisel, and H. Will. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 69:5437-5444.
17. Günther, S., H. Meisel, A. Reip, S. Miska, D. H. Krüger, and H. Will. 1992. Frequent and rapid emergence of mutated pre-C sequences in HBV from c-antigen positive carriers who seroconvert to anti-HBe during Interferon treatment. Virology 187:271-279.
18. Günther, S., and H. Will. Unpublished data.
19. Guo, W., M. Chen, T. S. B. Yen, and J.-H. Ou. 1993. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol. Cell. Biol. 13:443-448.
20. Hasegawa, K., J. Huang, S. A. Rogers, H. E. Blum, and T. J. Liang. 1994. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J. Virol. 68:1651-1659.
21. Horikita, M., S. Itoh, K. Yamamoto, T. Shibayama, F. Tsuda, and H. Okamoto. 1994. Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J. Med. Virol. 44:96-103.
22. Johnson, J. L., A. K. Raney, and A. McLachlan. 1995. Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter. Virology 208:147-158.
23. Kaneko, M., T. Uchida, M. Moriyama, Y. Arakawa, T. Shikata, K. Gotoh, and S. Mima. 1995. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J. Med. Virol. 47:204-208.
24. Kitamura, T., K.-I. Satoh, T. Tominaga, F. Taguchi, A. Tajima, K. Suzuki, Y. Aso, and Y. Yogo. 1994. Alteration in the JC polyomavirus genome is enhanced in immunosuppressed renal transplant patients. Virology 198:341-345.
25. Laskus, T., J. Rakela, J. L. Steers, R. H. Wiesner, and D. H. Persing. 1994. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology 107:1774-1780.
26. Laskus, T., J. Rakela, M. J. Tong, M. J. Nowicki, J. W. Mosley, and D. H. Persing. 1994. Naturally occurring hepatitis B virus mutants with deletions in the core promoter region. J. Hepatol. 20:837-841.
27. Lau, J. Y. N., V. G. Bain, H. M. Smith, G. J. M. Alexander, and R Williams. 1992. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 53:894-898.
28. Lenhoff, R. J., and J. Summers. 1994. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J. Virol. 68:5706-5713.
29. Lilienbaum, A., B. Crescenzo-Chaigne, A. A. Sall, J. Pillot, and E. Elfassi. 1993. Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer. J. Virol. 67:6192-6200.
30. Lo, W.-Y., and L.-P. Ting. 1994. Repression of enhancer 11 activity by a negative regulatory element in the hepatitis B virus genome. J. Virol. 68: 1758-1764.
31. López-Cabrera, M., J. Letovsky, K.-Q. Hu, and A. Siddiqui. 1990. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. USA 87:5069-5073.
32. Moriyama, K., T. Takada, Y. Tsutsumi, K. Fukada, H. Ishibashi, Y. Niho, and Y. Maeda. 1994. Mutations in the transcriptional regulatory region of the precore and core/pregenome of a hepatitis B virus with defective HBeAg production. Fukuoka Igaku Zasshi 85:314-322.
33. Okamoto, H., F. Tsuda, Y. Akahane, Y. Sugai, M. Yoshiba, K. Moriyama, T. Tanaka, Y. Miyakawa, and M. Mayumi. 1994. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68:8102-8110.
34. Penna, A., F. V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
35. Preisler-Adams, S., H.-J. Schlayer, T. Peters, F. Hettler, W. Gerok, and J. Rasenack. 1993. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch. Virol. 133:385-396.
36. Raney, A. K., A. J. Easton, D. R. Milich, and A. McLachlan. 1991. Promoterspecific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J. Virol. 65:5774-5781.
37. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
38. Repp, R., C. Keller, A. Borkhardt, A. Csecke, S. Schaefer, W. H. Gerlich, and F. Lampert. 1992. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch. Virol. 125:299-304.
39. Sato, S., K. Suzuki, Y. Akahane, K. Akamatsu, K. Akiyama, K. Yunomura, F. Tsuda, T. Tanaka, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1995. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Intern. Med. 122:241-248.
40. Su, H., and J.-K. Yee. 1992. Regulation of hepatitis B virus gene expression by its two enhancers. Proc. Natl. Acad. Sci. USA 89:2708-2712.
41. Takahashi, K., K. Aoyama, N. Ohno, K. Iwata, Y. Akahane, K. Baba, H. Yoshizawa, and S. Mishiro. 1995. The precore/core promoter mutant (T1762 A1764) of hepatitis B virus: clinical significance and an easy method for detection. J. Gen. Virol. 76:3159-3164.
42. Tranche, F., I. Bach, T. Chouard, B. David-Wattine, M. Pontoglio, F. Ringeisen, D. Sourdive, D. Thépot, and M. Yaniv. 1994. Hepatocyte nuclear factor 1 (HNF1) and liver gene expression, p. 155-181. In F. Tronche and M. Yaniv (ed.), Liver gene expression. R. G. Landes Company, Austin, Tex.
43. Tronche, F., F. Ringeisen, M. Blumenfeld, M. Yaniv, and M. Pontoglio. Analysis of the distribution of targets for a tissue specific transcription factor in the vertebrate genome. J. Mol. Biol, in press.
44. Uchida, T., M. Shimojima, K. Gotoh, T. Shikata, E. Tanaka, and K. Kiyosawa. 1994. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol. Immunol. 38:281-285.
45. Wang, Y., P. Chen, X. Wu, A.-L. Sun, H. Wang, Y.-A. Zhu, and Z.-P. Li. 1990. A new enhancer element, ENII. identified in the X gene of hepatitis B virus. J. Virol. 64:3977-3981.
46. Weimer, T., J. Salfeld, and H. Will. 1987. Expression of the hepatitis B virus core gene in vitro and in vivo. J. Virol. 61:3109-3113.
47. Wildner, G., and H. Will. Unpublished data.
48. Will, H., R. Cattaneo, G. Darai, F. Deinhard, H. Schellekens, and H. Schaller. 1985. Infectious hepatitis B virus from cloned DNA of known nuclcotide sequence. Proc. Natl. Acad. Sci. USA 82:891-895.
49. Will, H., W. Reiser, T. Weimer, E. Pfaff, M. Büscher, R. Sprengel, R. Cattaneo, and H. Schaller. 1987. Replication strategy of human hepatitis B virus. J. Virol. 61:904-911.
50. Yaginuma, K., and K. Koike. 1989. Identification of a promoter region for 3.6-kilobasc mRNA of hepatitis B virus and specific cellular binding protein. J. Virol. 63:2914-2920.
51. Yaginuma, K., Y. Shirakata, M. Kobayashi, and K. Koike. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. USA 84:2678-2682.
52. Yee, J.-K. 1989. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 246:658-661.
53. Yogo, Y., T. Kitamura, C. Sugimoto, K. Hara, T. Iida, F. Taguchi, A. Tajima, K. Kawabe, and Y. Aso. 1991. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients. J. Virol. 65:2422-2428.
54. Yuh, C.-H., Y.-L. Chang, and L.-P. Ting. 1992. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J. Virol. 66:4073-4084.
55. Yuh, C.-H., and L.-P. Ting. 1990. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J. Virol. 64:4281-4287.
56. Yuh, C.-H., and L.-P. Ting. 1991. C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus. Mol. Cell. Biol. 11:5044-5052.
57. Yuh, C-H., and L.-P. Ting. 1993. Differentiated liver cell specificity of the second enhancer of hepatitis B virus. J. Virol. 67:142-149.
58. Zacharias, D. A., N. Garamszegi, and E. E. Strehler. 1994. Characterization of persistent artifacts resulting from RT-PCR of alternatively spliced mRNAs. BioTechniques 17:652-655.
59. Zhang, P., and A. McLachlan. 1994. Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines. Virology 202:430-440.
60. Zhang, P., A. K. Raney, and A. McLachlan. 1993. Characterization of functional SpI transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J. Virol. 67:1472-1481.
61. Zhou, D.-X., and T. S. B. Yen. 1990. Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer. J. Biol. Chem. 265:20731-20734.